Abbott

Abbott India rises 4% on strong Q4 performance

Abbott India's profit jumped 24.1 per cent to Rs 287.1 crore in the March quarter of FY24 (Q4FY24), from Rs 231.4 crore in the March quarter of FY23 (Q4FY23)

Abbott India recalls batches of Antacid Digene gel

In its letter, the DCGI warned that Digene may be unsafe and its use may result in adverse reaction

DCGI issues advisory as US-based Abbott recalls batches of Digene gel

The DCGI has cautioned against the consumption of Abbott's antacid Digene gel citing safety concerns, even as the US-based drugmaker recalled several batches of the medicine manufactured at its Goa facility. According to a letter by the Drugs Controller General of India (DCGI), it was reported on August 9 that a bottle of Digene Gel (mint flavour), batch no 51030307, used by customers was of regular taste (sweet) and light pink in colour whereas another bottle of the same batch was of white colour with bitter taste and pungent odour as per a complaint. "Accordingly, M/s Abbott India Limited, Verna Industrial Estate, Salcette, Goa- vide letter dated August 11, 2023, informed DCGI office for voluntary recall of impugned product Digene Mint flavour batch no 51030307 and Digene Gel orange having batch no 50035107, 50035207, 50035307, 50035407 and voluntary stopped production of all variants of Digene Gel manufactured at their Goa facility," the DCGI letter stated. Further, Abbott India

Abbott beats quarterly profit estimates on demand for medical devices

Abbott's diagnostic sales came in at $2.3 billion in the quarter, in line with analysts' average estimates.

Abbott recalls a batch of thyroid disorder drug for labelling error

Thyronorm has no quality issue, mislabeled batch was invoiced in Madhya Pradesh and Telangana: Company

Wall Street struggles as losses in Abbott counter Netflix's gains

US 10-year Treasury yield at highest since July 2008; Netflix jumps after reversing customer losses; P&G, Travelers post upbeat earnings; PHLX Housing Index falls 3% on weak US housing data

Core brands, new launches to help Abbott India stock outperform: Analysts

Analysts expect double-digit growth for pharma major even if Q1 disappointed

Tamil Nadu agency blacklists Abbott for five years for hiding information

TNMSC Managing Director Deepak Jacob said the step was taken after a complaint from Paris Legal Cell in Chennai

Biden invokes Defense Production Act for baby formula shortage in US

The Defense Production Act order requires suppliers of formula manufacturers to fulfil orders from those companies before other customers, in an effort to eliminate production bottlenecks

US allows more baby formula imports to fight shortage due to Abbot recall

The shortage stems from a February recall by Abbott that exacerbated ongoing supply chain disruptions among formula makers, leaving fewer options on stores shelves across much of the country

Pharma company Abbott ties up with health tech firms for diabetes care

Abbott on Tuesday said it has tied up with health-tech firms like BeatO, Sugar.fit, PharmEasy, GOQii, 1MG and Zyla for diabetes care

Modi meets ex-Aus PM Abbott; leaders vow to strengthen economic cooperation

The two leaders emphasised that enhanced economic cooperation between India and Australia would help the two countries

Abbott profit more than doubles as medical device sales rebound

(Reuters) -Abbott Laboratories' quarterly profit more than doubled on Thursday, due to strength in its diagnostics business and a rebound in medical device sales.

Abbott's Korea-imported PanBio Covid-19 self test launched at Rs 325

Firm expects demand from both, institutions and retail consumers, will import kits in 4-pack sizes from Korean plant; Test linked with NAVICA app which uploads results on ICMR website

Abbott launches pea-sized life-saving device for babies with hole in heart

The device is particularly useful for tiny babies who may not be able to undergo surgery to repair their hearts

Covid-19 pandemic: Abbott to supply over 1 million antibody tests to India

Abbott said it is already in the process of delivering antibody tests to leading government and private hospitals and labs across different states

Covid-19 impact: India looks to lure more than 1,000 US firms out of China

In talks with Medtronic and Abbott on relocating units

Abbott India Q2 net up 30% at Rs 178 crore, total income rises 8%

The company had posted a profit of Rs 137.68 crore for the year-ago period, Abbott India said in a filing to BSE

Abbott exits MNC lobby group, may join Indian Pharmaceuticals Alliance

Abbott may now join Indian Pharmaceuticals Alliance which represents domestic generic drug makers

Abbott likely to launch second-generation Falcon stent

Plans a second-generation variety of Absorb for the Indian market